Cite

HARVARD Citation

    Hatem, R. et al. (n.d.). Vandetanib as a potential new treatment for estrogen receptor‐negative breast cancers. International journal of cancer. 138 (10), pp. 2510-2521. [Online]. 
  
Back to record